Segulah Medical Acceleration Overview

Segulah Medical Acceleration (SMA) is a Scandinavian-based investment company focusing on innovative medical technology companies with global potential. SMA aims to bridge the gap between Europe's exceptional R&D and its full realization by offering not only capital but also strategic insights, industry expertise, and access to extensive networks. The firm targets investments that create long-term solutions to critical global health challenges, supporting technology-driven companies in the medtech sector that have developed transformative products with the potential to improve patient outcomes and healthcare delivery. SMA's geographic investment remit is focused on Scandinavia and other Western European countries, with a portfolio that includes medical devices, diagnostics, life science tools, and digital technologies. The firm has more than SEK 1.3 billion in investable funds, with the team personally committing nearly 20% of the total fund, reflecting their strong belief in their mission. More than 60% of the capital comes from well-established institutional investors, including two leading Swedish pension funds, a prominent European foundation, and a Swedish government entity.

Is Segulah Medical Acceleration the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Segulah Medical Acceleration, along with a list of other relevant VCs, is available on Hopohopo.io.